Position in BHVN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$37,480,144
+$25,412,573 QoQ
Shares Held
2,518,827
+76.6% QoQ
Ownership
1.67%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#15
of 294 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 63%
Shared 0%
None 37%
Common Shares in BHVN Over Time
Shares Held
Position Value (USD)
Derivatives in BHVN
reported options exposure · as of Dec 31, 2025CallValue
$1,189,966
CallShares
105,400
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. BHVN ranks #44 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,450,825 | $1,020,369,609 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
17,466,641 | $618,144,423 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
3,399,221 | $416,676,508 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
712,259 | $353,800,411 | |
| 5 | MRNA |
Moderna, Inc.
|
4,463,211 | $312,558,664 | |
| 6 | INSM |
INSMED Inc
|
2,584,446 | $275,553,630 | |
| 7 | ABVX |
Abivax S.A.
|
1,844,918 | $245,853,771 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
401,708 | $215,697,109 |
All Filings in BHVN
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $37,480,144 | 2,518,827 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $12,067,571 | 1,426,427 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $13,416,560 | 1,188,358 | Shares | Defined | 2026-01-29 | |
| 2025-12-31 | $1,189,966 | 105,400 | Call | Defined | 2026-01-29 | |
| 2025-09-30 | $16,806,171 | 1,119,665 | Shares | Defined | 2025-11-13 | |
| 2025-09-30 | $759,506 | 50,600 | Call | Defined | 2025-11-13 | |
| 2025-06-30 | $7,475,773 | 529,821 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $15,310,425 | 636,873 | Shares | Defined | 2025-05-13 | |
| 2025-03-31 | $432,720 | 18,000 | Put | Defined | 2025-05-13 | |
| 2025-03-31 | $182,704 | 7,600 | Call | Defined | 2025-05-13 | |
| 2024-12-31 | $27,927,341 | 747,720 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $6,300,966 | 126,095 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $11,080,055 | 319,218 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $13,055,431 | 238,717 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $89,837 | 2,099 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $2,304,173 | 88,588 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $77,261 | 3,230 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,864,998 | 136,530 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $8,577,173 | 617,952 | Shares | Defined | 2023-02-08 | |
| No filing history on record for this holder in this stock. | ||||||